Michael D. Celestin Jr., Ph.D.

Director of the Louisiana Tobacco Control Initiative
Assistant Professor in the LSU Health New Orleans School of Public Health.

[Michael D. Celestin Jr., Ph.D. @ProfCelestin]

I've been looking for YOU - a new postdoctoral fellow to join my research lab - the Tobacco Control Initiative (TCI) at LSU Health New Orleans!

Location: New Orleans, LA
Duration: 2 years or more
Focus: Tobacco Cessation
Apply at https://t.co/0nCk3vYtMt.

[Michael D. Celestin Jr., Ph.D. @ProfCelestin]

Did you know breast cancer is the most common cancer among women in Louisiana? I'm wearing pink all month to bring awareness and raising funds for resources and research. 🎀 Make a tax deductible donation to my ACS MWP-NO campaign. Every dollar helps → https://t.co/N6EJknvaz6 💖

[Michael D. Celestin Jr., Ph.D. @ProfCelestin]

1 in 3 women don't get screened for breast cancer, and unfortunately, 1 in 8 will be diagnosed with it in their lifetime. Help me change that. I'm an ambassador for the American Cancer Society's Men Wear Pink campaign. Support me and this cause via https://t.co/rpdNUFKWyE

[Michael D. Celestin Jr., Ph.D. @ProfCelestin]

Good morning! New @TreatmentSRNT alert! Read this pre-print article examining the use of blunt and cigar use among people 12 and older in the U.S. between 2015-2019. Findings can inform policy, treatment, and educational efforts. https://t.co/DBGKaqntEP

[Michael D. Celestin Jr., Ph.D. @ProfCelestin]

@TreatmentSRNT A recent systematic review and meta-analysis suggested that Cytisine was safe and more than twice as likely to improve smoking cessation compared with placebo but not as much over other cessation medications. Read more about it at https://t.co/FyA3IDe7OF.

[Michael D. Celestin Jr., Ph.D. @ProfCelestin]

Share this with someone you know looking to have a great time in New Orleans...while working on research projects with an outstanding team of transdisciplinary scientists at LSU! 🙂

[Michael D. Celestin Jr., Ph.D. @ProfCelestin]

I've been looking for YOU - a new postdoctoral fellow to join my research lab - the Tobacco Control Initiative (TCI) at LSU Health New Orleans!

Location: New Orleans, LA
Duration: 2 years or more
Focus: Tobacco Cessation
Apply at https://t.co/0nCk3vYtMt.

[Michael D. Celestin Jr., Ph.D. @ProfCelestin]

I've been looking for YOU - a new postdoctoral fellow to join my research lab - the Tobacco Control Initiative (TCI) at LSU Health New Orleans!

Location: New Orleans, LA
Duration: 2 years or more
Focus: Tobacco Cessation
Apply at https://t.co/0nCk3vYtMt.

[Michael D. Celestin Jr., Ph.D. @ProfCelestin]

Read AACR and ASCO Joint Policy Statement on Electronic Nicotine Delivery Systems at https://t.co/qK8ifuXSJb

[National Cancer Institute @theNCI]

NCI is excited to welcome @NCIDirector Dr. Monica Bertagnolli! Appointed by @POTUS, today Dr. Bertagnolli begins as NCI's 16th and first female director. #NCIFuture

[National Cancer Institute @theNCI]

Dr. Bertagnolli comes to NCI from @brighamwomens in Boston, MA, where she worked as a surgical oncologist and a leader in the field of clinical #oncology. Learn more about the @NCIDirector. https://t.co/oxK1eWwZcu #NCIFuture @danafarber

[LA CaTS Center IDeA-CTR @LACaTSCenter]

The @LACaTSCenter Professional Development Core welcomes the new cohort of Roadmap Scholars for 2022-24. Congratulations to Dr. Celestin @LSUHealthNO, Dr. Mey @PBRCNews, and Dr. Bhargava @TulaneMedicine! @NIGMSTraining #IDeACTR #Louisianaresearch https://t.co/5T1w1dLzZF

[Michael D. Celestin Jr., Ph.D. @ProfCelestin]

Save the date! Join the @NASEM_Health #PopHealthRT on August 31 for a webinar, "Voting & Health: Actions for Every Sector," featuring training on #VoterRegistration and other tools for #CivicEngagement. Register now:  https://t.co/bndo4NaPG7

[Dr. Robert M. Califf @DrCaliff_FDA]

Nicotine is powerfully addictive. Making cigarettes and other combusted tobacco products minimally addictive or non-addictive would help save lives.

[Michael D. Celestin Jr., Ph.D. @ProfCelestin]

When you have a moment, take a look at my and @rebekahgeemd's recent publication, "The Epidemic During the Pandemic: Assessing the Federal Drug Administration’s Efforts to Curb Youth Smoking After Passage of HR2339 by Congress," at https://t.co/lfVt3NPpXv

[AJPH @AMJPublicHealth]

AJPH’s July issue is now online.

The issue features a special section in which articles examine flavors, devices, and brands before and after the 2020 FDA guidance for industry on #ecigarettes.

https://t.co/peY2Qyw44X

[Michael D. Celestin Jr., Ph.D. @ProfCelestin]

I can't stop listening to this compelling story on "The impact of COVID-19, a million deaths" in https://t.co/fzfsxJzSHA

[Michael D. Celestin Jr., Ph.D. @ProfCelestin]

https://t.co/PhFjYbk0L6

[Michael D. Celestin Jr., Ph.D. @ProfCelestin]

Access to care is limited for Medicaid enrollees in part because Medicare and private insurers provide physicians with higher payment rates. https://t.co/eD6Y0RpVrJ

[Michael D. Celestin Jr., Ph.D. @ProfCelestin]

Opportunities For Equity In Research Grantmaking | Health Affairs Forefront https://t.co/vo40yrBAEU

[Michael D. Celestin Jr., Ph.D. @ProfCelestin]

Opportunity for a full-time post-doctoral fellow https://t.co/0YQ5CYY4cJ